TED · 517704-2025 · 2025-08-07

Netherlands – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Levering gordelroosvaccin Shingrix

Nederland – Algemene infectiewerende middelen voor systemisch gebruik, vaccins, antineoplastica en immunomodulerende middelen – Levering gordelroosvaccin Shingrix

Buyer
SamenTwente
Netherlands · NLD · NUTS NLD
Category (CPV)
33650000
CPV 336xxx
Procedure
neg-wo-call veat
Currency
EUR

What this category covers

This notice is classified under the EU's Common Procurement Vocabulary in the medical equipments, pharmaceuticals and personal care products division. The CPV is a hierarchical eight-digit taxonomy used across every EU public-procurement notice so contracts can be searched, compared and analysed by sector regardless of the publication language.

TED — Tenders Electronic Daily — is the EU's official journal for public procurement. This notice is publication #517704 from the 2025 series; every contract above the EU thresholds (currently €143,000 for central-government supplies and services, €5.5M for works) must be advertised here.

This is a metadata summary. The full notice — including contract conditions, technical specs, attachments, and award outcome — lives on the official TED website.

Open notice on ted.europa.eu →

Frequently asked questions

Who is the contracting authority?
The contracting authority is SamenTwente, based in Netherlands (NUTS region NLD).
What is the CPV category of this tender?
The main Common Procurement Vocabulary (CPV) code is 33650000, which corresponds to CPV 336xxx.
Which country does this tender relate to?
This tender was published by a contracting authority in Netherlands (NLD).
What procedure type is used?
This tender uses the neg-wo-call procedure (notice type: veat).
Where can I find the official tender notice?
The full official notice, including contract conditions, technical specifications, attachments and any award outcome, is published on TED — Tenders Electronic Daily — under publication 517704-2025.